Skip to content

Senior Director, Clinical Development

IDEAYA Biosciences · South San Francisco, CA

Posted November 17, 2026

DirectorClinical scienceGCPOn site
US$338k to 418k a yearApply

Quick facts

Experience
12+ years
Education
PhD or MD
Skills mentioned
GCP, IND / NDA / BLA, CMC regulatory, Protocol development, Medical writing, KOL engagement

Pulled from the ad below. The full ad has the details.

Non-Solicitation Policy and Notice to Agencies and Recruiters:

IDEAYA's Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees, managers, and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships .  Submission of unsolicited candidate resumes by agencies or recruiters with or without a contract in place with IDEAYA Biosciences Inc. will not create any implied obligation.  Failure to comply with this policy will result in disqualification from current and future business opportunities with IDEAYA Biosciences.  All recruiting and talent agency decisions are strictly managed by the internal IDEAYA Human Resources function.  All communication by external agencies and recruiters must be directed to humanresources ideayabio.com.  We ask that you only email your interest once.

Job Summary

About IDEAYA Biosciences

IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates, or ADCs, for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.

When you're at IDEAYA, you will be in the midst of brilliant minds working on precision medicine therapies to help cancer patients. We are passionate and committed about being on the forefront of oncology medicine, which means we all have a high internal drive that is at the very core of every person at IDEAYA. We are inquisitive, ask deep questions, and are data-driven innovators who like to collaborate and use team work to move science forward. For more information, please see www.ideayabio.com.

Location: South San Francisco, CA.

Position Summary

IDEAYA is seeking a Senior Director, Clinical Development to join the Development team. The Senior Director, Clinical Development will serve as the physician leader for IDE849 and possibly additional assets, with full accountability for clinical strategy, study execution, and scientific integrity through registration. This individual will own the medical voice for their clinical programs, both internally and externally. In the near term, the primary focus will be IDE849, encompassing a registrational study in post-tarlatamab ES-SCLC, a registrational study in 2L+ NEC, and an active combination program with durvalumab and IDE161 (PARG inhibitor) targeting first-line SCLC. Additional priorities include initiating a frontline strategy for IDE849 and providing leadership for other areas of clinical development. The role requires deep oncology expertise and a strong command of accelerated and traditional approval strategies.

This position is based in our South San Francisco headquarter offices and required to be onsite four days per week per our company policy.

Reporting to: Senior Vice President, Early Phase Clinical Development

Job Description

What you’ll do

Clinical Strategy & Study Design

  • Assume immediate ownership of the Clinical Development Plan (CDP) and Target Product Profile (TPP) for IDE849 across SCLC and NEC indications, and take ongoing ownership of CDPs and TPPs for IDE849
  • Lead protocol design and amendments for the IDE849-001 master study, including the Phase 3 SCLC RCT registrational arm, the NEC registrational study, and the IDE849 IDE161 combination program
  • Refine dose optimization strategy, randomized dose expansion design, and endpoint selection in alignment with FDA guidance
  • Drive the accelerated approval strategy for both SCLC (post-tarlatamab) and NEC (DLL3-unselected), including ORR/DOR endpoint design and OS confirmatory endpoint planning for SCLC

Medical Monitoring & Safety

  • Serve as medical monitor for IDE849-001; review safety data on an ongoing basis across all cohorts
  • Lead Safety Review Committee meetings and interface with the external Data Safety Monitoring Board (DSMB)
  • Oversee toxicity monitoring
  • Author and review medical sections of protocols, INDs, investigator brochures, clinical study reports, and BLA submissions

Regulatory & Health Authority Engagement

  • Lead preparation for and participation in FDA meetings including SCLC dose optimization discussions
  • Drive Breakthrough Therapy Designation strategy and submission (targeted Q1 2027)
  • Support Fast Track and Orphan Drug Designation applications as appropriate
  • Partner with Regulatory Affairs on global development strategy, including EU and other ex-US health authority interactions

External Engagement

  • Build and maintain relationships with key opinion leaders in thoracic oncology, neuroendocrine tumors, and other relevant tumor types
  • Represent IDEAYA at major scientific conferences, including ASCO and ESMO
  • Support investigator identification and engagement across the approximately 200 planned IDE849-001 sites and other asset study sites
  • Contribute to publication strategy; author and co-author manuscripts and abstracts

Cross-Functional Leadership

  • Serve as the medical lead on the IDE849 Program Team, providing direction across Clinical Operations, Translational Medicine, Regulatory Affairs, CMC, and Commercial functions
  • Partner with Translational Medicine on DLL3 CDx strategy, including the Ventana/Roche IHC development program, prospective and retrospective biomarker analysis
  • Collaborate with Business Development on potential DLL3 T-cell engager partnership strategy for first-line SCLC
  • Provide medical input on competitive intelligence and commercial positioning for the DLL3 ADC franchise

Requirements

  • MD or MD/PhD required; board certification or eligibility in Medical Oncology, Hematology/Oncology, or Pulmonary Oncology strongly preferred
  • Minimum 12 years of oncology clinical development experience in the pharmaceutical or biotechnology industry
  • Direct experience designing and executing Phase 1, 2, and 3 oncology trials, including dose escalation and expansion studies
  • Solid understanding of FDA accelerated approval pathways, ORR/DOR endpoint strategy, and confirmatory study requirements
  • Experience in thoracic oncology — SCLC, NSCLC, NEC, or related tumor types — in either clinical practice or industry drug development
  • Strong GCP knowledge and familiarity with IND and BLA regulatory requirements
  • Experience with ADC programs — ideally with TOP1i payload agents — and familiarity with ADC-class toxicities, including ILD
  • Prior experience in neuroendocrine tumors (epNEC, LCNEC, GEP-NEC) in either a clinical or drug development setting
  • Familiarity with DLL3 biology and the competitive SCLC treatment landscape, including tarlatamab, ZL-1310, and B7-H3 ADC programs
  • Experience with novel-novel combination development and contribution-of-components regulatory strategy
  • Prior FDA Type B, C and/or D meeting experience; BTD submission experience a plus
  • Established KOL relationships across multiple oncology indications
  • Publication record in SCLC, NEC, or ADC oncology

All employees are expected to act with integrity and in full compliance with applicable laws, regulations, and IDEAYA policies, including IDEAYA’s Code of Conduct.

Employees must demonstrate good judgement and ethical behavior in all business activities, maintain patient and product safety as a top priority, and report any suspected violations of law or Company policy through appropriate channels

Travel required: Yes

Percentage of time in a year: 20%

Domestic/International: Both

Physical Demands and Work Environment

The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job.

  • The employee is required to be on-site in our company offices for a minimum of four days per week.
  • The employee will be required to stand and/or walk for up to 3 hours a day and sit for up to 8      hours a day; use hands to handle or feel objects including keyboard and telephones.
  • The employee may occasionally lift and/or move up to 15 pounds.
  • The noise level in the work environment will vary by location but is usually moderate.

Lab-based Employees

  • The employee is required to be onsite 5 days per week
  • The employee will be required to use their hands to manipulate objects including research chemicals, labware, equipment interfaces, and keyboards both inside and outside of fumehoods, and the employee will be required to carry lab material weighing up to 10 pounds (e.g. racks of solvent-filled test tubes) between fumehoods or between laboratory rooms
  • The employee will be required to work while wearing appropriate PPE, including lab coat, protective gloves, and safety glasses

Total Rewards

Along with our inspiring mission, and highly collaborative and inclusive environment, IDEAYA offers a competitive total rewards package that reflects our pay-for-performance philosophy where employees are eligible to be considered for merit-based salary increases, company discretionary short-term incentive plan participation, and company discretionary stock option awards (based on board approval).  Our comprehensive benefits package includes, but is not limited to, medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents), 401k, ESPP, and wellness programs.

The expected salary range for the role of Senior Director, Clinical Development is $338,000 - $418,000. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the office location where this open position is located, the final candidates’ experience within their profession, experience in the disease areas we are striving to make an impact in as a company, length of time within the industry, educational background, and performance during the interview process.

The Company complies with all laws respecting equal employment opportunities and does not discriminate against applicants with regard to any protected characteristic as defined by federal, state, and local law.

IDEAYA is an equal opportunity employer. In accordance with applicable law, IDEAYA does not discriminate in hiring or otherwise in employment based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. EOE/AA/Vets.

We are committed to providing reasonable accommodation to qualified individuals with disabilities. If you need assistance or an accommodation due to a disability, please get in touch with us at hr ideayabio.com.

Source: IDEAYA Biosciences's career site. PharmoniQ shows this job as posted and links to the original. Check the employer's page for the latest details.